Cargando…

miR106a Promotes the Growth of Transplanted Breast Cancer and Decreases the Sensitivity of Transplanted Tumors to Cisplatin

OBJECTIVE: To explore the effect of miR106a on the growth of breast cancer xenografts and the sensitivity of chemotherapeutic agents. METHODS: Breast cancer cell lines (MDA-MB231 and MCF7) were transfected with an miR106 mimic and miR106a inhibitor. BALB/c female nude mice were selected to construct...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Faping, Li, Junhui, Zhang, Peijin, Zhang, Hui, Cao, Xuchen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968812/ https://www.ncbi.nlm.nih.gov/pubmed/32021439 http://dx.doi.org/10.2147/CMAR.S231375

Ejemplares similares

Exosomal transfer of miR‐106a‐5p contributes to cisplatin resistance and tumorigenesis in nasopharyngeal carcinoma
por: Li, Jiaxing, et al.
Publicado: (2021)

The Three Paralogous MicroRNA Clusters in Development and Disease, miR-17-92, miR-106a-363, and miR-106b-25
por: Khuu, Cuong, et al.
Publicado: (2016)

Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
por: Larki, Pegah, et al.
Publicado: (2018)

The Oncogenic Relevance of miR-17-92 Cluster and Its Paralogous miR-106b-25 and miR-106a-363 Clusters in Brain Tumors
por: Gruszka, Renata, et al.
Publicado: (2018)

Long non-coding RNA HAND2-AS1/miR-106a/PTEN axis re-sensitizes cisplatin-resistant ovarian cells to cisplatin treatment
por: Li, Lijun, et al.
Publicado: (2021)

Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma
por: Nakka, Manjula, et al.
Publicado: (2017)

HOTAIR mediates cisplatin resistance in nasopharyngeal carcinoma by regulating miR-106a-5p/SOX4 axis
por: Cao, Wei, et al.
Publicado: (2022)

MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer
por: Li, Jiarui, et al.
Publicado: (2012)

miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging
por: Hackl, Matthias, et al.
Publicado: (2010)

Growth-Promoting Role of the miR-106a∼363 Cluster in Ewing Sarcoma
por: Dylla, Layne, et al.
Publicado: (2013)

Diagnostic and prognostic value of miR-106a in colorectal cancer
por: Hao, Haibin, et al.
Publicado: (2016)

Altered expression of serum miR‐106a, miR‐19b, miR‐17, and PTEN in patients with idiopathic membranous nephropathy
por: Wu, Lina, et al.
Publicado: (2021)

Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
por: Huh, J H, et al.
Publicado: (2013)

miR-106b suppresses pathological retinal angiogenesis
por: Ménard, Catherine, et al.
Publicado: (2020)

miR-106b as an emerging therapeutic target in cancer
por: Sagar, Surendra Kumar
Publicado: (2021)

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
por: Schee, Kristina, et al.
Publicado: (2012)

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2018)

Cisplatin decreases cyclin D2 expression via upregulating miR-93 to inhibit lung adenocarcinoma cell growth
por: Xie, Ning, et al.
Publicado: (2019)

miR-1271 enhances the sensitivity of colorectal cancer cells to cisplatin
por: Yao, Huixiang, et al.
Publicado: (2019)

Usefulness of serum miR-1246/miR-106b ratio in patients with esophageal squamous cell carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2020)

Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM
por: Dai, Dong-Wei, et al.
Publicado: (2013)

HBeAg-induced miR-106b promotes cell growth by targeting the retinoblastoma gene
por: Samal, Jasmine, et al.
Publicado: (2017)

Overexpression of miR-106a enhances oxaliplatin sensitivity of colorectal cancer through regulation of FOXQ1
por: Liu, Zhihu, et al.
Publicado: (2020)

miR-200b and miR-200c co-contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases
por: Liu, Jue, et al.
Publicado: (2019)

miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression
por: Choi, Nahyun, et al.
Publicado: (2015)

Effects of crocin on T-bet/GATA-3 ratio, and miR-146a and miR-106a expression levels in lung tissue of ovalbumin-sensitized mice
por: Aslani, Mohammad Reza, et al.
Publicado: (2022)

Overexpression of miR-26b decreases the cisplatin-resistance in laryngeal cancer by targeting ATF2
por: Tian, Linli, et al.
Publicado: (2017)

miR-106a deficiency attenuates inflammation in murine IBD models.
por: Sanctuary, Megan R., et al.
Publicado: (2018)

Involvement of miR-106b in tumorigenic actions of both prolactin and estradiol
por: Chen, Kuan-Hui Ethan, et al.
Publicado: (2017)

Overview of miR-106a Regulatory Roles: from Cancer to Aging
por: Daneshpour, Maryam, et al.
Publicado: (2023)

Nourin-Dependent miR-137 and miR-106b: Novel Early Inflammatory Diagnostic Biomarkers for Unstable Angina Patients
por: Elgebaly, Salwa A., et al.
Publicado: (2021)

HOTAIR Promotes Cisplatin Resistance of Osteosarcoma Cells by Regulating Cell Proliferation, Invasion, and Apoptosis via miR-106a-5p/STAT3 Axis
por: Guo, Jiankuo, et al.
Publicado: (2020)

Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma
por: Shi, Bao-Min, et al.
Publicado: (2017)

Doxorubicin and Cisplatin Modulate miR-21, miR-106, miR-126, miR-155 and miR-199 Levels in MCF7, MDA-MB-231 and SK-BR-3 Cells That Makes Them Potential Elements of the DNA-Damaging Drug Treatment Response Monitoring in Breast Cancer Cells—A Preliminary Study
por: Mizielska, Anna, et al.
Publicado: (2023)

Circular RNA hsa_circ_000984 promotes colon cancer growth and metastasis by sponging miR-106b
por: Xu, Xiao-Wu, et al.
Publicado: (2017)

MiR-106b inhibitors sensitize TRAIL-induced apoptosis in hepatocellular carcinoma through increase of death receptor 4
por: Xu, Changlong, et al.
Publicado: (2017)

Macrophage secretion of miR-106b-5p causes renin-dependent hypertension
por: Oh, J., et al.
Publicado: (2020)

MiR-222 Targeted PUMA to Improve Sensitization of UM1 Cells to Cisplatin
por: Jiang, Fangfang, et al.
Publicado: (2014)

MiR-1208 Increases the Sensitivity to Cisplatin by Targeting TBCK in Renal Cancer Cells
por: Kim, Eun-Ae, et al.
Publicado: (2019)

The role of miR-106p-5p in cervical cancer: from expression to molecular mechanism
por: Yi, Yuexiong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mo5i6pp080fs3496blvpukh7lc